Harwin Peter Evan 4
4 · Viridian Therapeutics, Inc.\DE · Filed Jun 16, 2021
Insider Transaction Report
Form 4
Harwin Peter Evan
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-03+12,500→ 12,500 totalExercise: $16.60Exp: 2031-06-03→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]The option vests in full upon the earlier to occur of (i) June 3, 2022 or (ii) the Issuer's 2022 annual meeting of stockholders, subject to Reporting Person's continued service on the Board.